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Community and Clinical Epidemiology of Borderline Personality Disorder 
 
William D. Ellison, PhD (corresponding author),1 Lia Rosenstein,2 Theresa A. Morgan, PhD,3 
and Mark Zimmerman, MD4  
 
Synopsis: Several studies of the prevalence of Borderline Personality Disorder (BPD) in 
community and clinical settings have been carried out to date. Although results vary according to 
sampling method and assessment method, median point prevalence of BPD is roughly 1%, with 
higher or lower rates in certain community subpopulations. In clinical settings, BPD prevalence 
is around 10-12% in outpatient psychiatric clinics and 20-22% among inpatient clinics. Further 
research is needed to identify the prevalence and correlates of BPD in other clinical settings (e.g., 
primary care) and to investigate the impact of demographic variables on BPD prevalence. 
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Key Points:  
 
1. Point prevalence of BPD is roughly 1% in community settings. 
2. Point prevalence of BPD in clinical settings is approximately 12% in outpatient 
psychiatric clinics and 22% in inpatient psychiatric clinics. 
3. Prevalence estimates of BPD depend greatly on the use of standardized, validated 
methods for diagnosis; unstandardized or informal methods tend to underdiagnose BPD. 
4. Prevalence of BPD varies according to certain demographic factors, such as age; more 
research is needed into the demographic correlates of the disorder. 
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Community and Clinical Epidemiology of Borderline Personality Disorder 
This paper concerns the community and clinical epidemiology of Borderline Personality 
Disorder (BPD) – its prevalence and characteristics in different community and treatment 
settings and among different populations of individuals. We focus on a categorically defined 
BPD entity, even if the exact definition varies across different diagnostic systems. Nevertheless, 
there is compelling evidence that BPD is not a discrete condition that pertains to a class of 
individuals (alongside another, complementary “healthy” class) but instead a dimensionally 
distributed construct. Taxometric studies using different operationalizations of BPD and 
conducted among different populations largely agree on this point,1-4 as does a comparison of the 
fit of categorical and dimensional models of the latent structure of BPD.5 On the other hand, the 
distribution of dimensionally defined borderline pathology is inadequately understood, and the 
extant large-scale research has generally assumed a categorical model for BPD. Therefore, the 
current review will focus on the epidemiology of the categorically defined BPD syndrome. 
 We also wish to highlight the importance of measurement for estimates of BPD 
prevalence, as studies suggest that clinicians who do not use a dedicated assessment tool to 
screen for, or diagnose, BPD tend to neglect the diagnosis. For example, Zimmerman & Mattia6 
found that clinicians left to their own judgments diagnosed BPD in only 0.4% of outpatients, 
compared to 14.4% by structured interview (a rate much more consistent with established 
outpatient prevalence rates of BPD). Simply providing results of positive BPD diagnoses to 
intake clinicians who had not used the interview themselves raised the diagnosis rate of BPD to 
7%, suggesting the clinical utility of this information and the extent to which it can be neglected 
in routine practice. Likewise, Comtois and Carmel7 compared BPD diagnoses produced by 
routine clinical records and diagnoses from semi-structured research interviews among 
outpatients in a public mental health service. They found that the interviews identified BPD in 
15.1% of patients, whereas this diagnosis appeared in records 6.9% of the time. Even when 
clinicians have the information necessary to make a BPD diagnosis, they often miss it. Hillman, 
Stricker, & Zweig8 presented clinical vignettes describing individuals with major depression 
only, or major depression with comorbid BPD, to 186 experienced psychologists. Only 14% of 
respondents correctly made a BPD diagnosis when it was warranted.  
Because of this discrepancy, when estimating community prevalence, we will focus on 
epidemiological studies using a well-validated instrument for diagnosing BPD, although there 
are some notable exceptions (described below) in which a validated instrument was not used but 
its prevalence was estimated systematically at a later date. However, for clinical prevalence, we 
will review both BPD prevalence estimates derived from a BPD-specific diagnostic measure and 
those estimates derived from unstructured clinical assessment, and we will highlight several 
additional studies that illustrate the importance of assessing for BPD in clinical settings.  
Major Epidemiological Studies of BPD in the Community: United States 
In the United States, several large epidemiological studies assessing BPD have been 
conducted since the introduction of the DSM-III criteria for the disorder. Table 1 shows the 
prevalence rates obtained from each of these studies. The first of these was the National Institute 
of Mental Health’s Epidemiologic Catchment Area studies (ECA).9 The ECA studies collected 
interviews from over 18,000 adult individuals across five catchment areas (New Haven, 
Baltimore, St. Louis, central North Carolina, and Los Angeles), oversampling elderly, Black, and 
Hispanic respondents. The NIMH Diagnostic Interview Schedule (DIS), a structured interview, 
provided information about DSM-III disorders. However, the only personality disorder directly 
assessed during this effort was antisocial PD. Despite the fact that BPD was not directly assessed 
in the ECA studies themselves, three later studies attempted to derive BPD prevalence estimates 
from ECA respondents. Swartz and colleagues10 used an empirically-derived algorithm relating 
DIS symptoms to items from the Diagnostic Interview for Borderlines (DIB) to estimate the 
prevalence of BPD in respondents from Wave II of the North Carolina site ECA study. 
Separately, Samuels and colleagues11 followed 810 individuals from the Baltimore site who were 
selected for “clinical reappraisal” by psychiatrists. The reappraisals used a semistructured 
diagnostic instrument (the Standard Psychiatric Examination) that was not designed to diagnose 
DSM-III personality disorders but rather general psychiatric symptoms, history, and functioning. 
Information about BPD was later coded from these interviews. Finally, Samuels and colleagues12 
reported on the prevalence of BPD among 742 individuals from the Baltimore ECA follow-up 
survey,13 some of whom were among those examined by psychiatrists in the original ECA 
clinical reappraisal. (Other respondents in Samuels et al.’s sample had a lifetime diagnosis of one 
of six Axis I disorders at follow-up or were drawn randomly from the remaining ECA 
respondents.) These individuals were diagnosed via the International Personality Disorder 
Examination (IPDE).  
The National Comorbidity Survey (NCS)14 provided an update of the ECA findings using 
DSM-III-R criteria rather than those of DSM-III based on a stratified probability sample of 
individuals in the continental United States rather than a set of discrete catchment areas. 
Diagnoses were made using the World Health Organization’s Composite International 
Diagnostic Interview (CIDI), which was based on the DIS and, like its predecessor, was fully 
structured so that it could be used by lay interviewers. However, also like the ECA studies, the 
battery used in the NCS only included antisocial PD from among the DSM-III-R personality 
disorders, and no estimate of the prevalence of BPD in the NCS data has been made to date. 
Crawford and colleagues15 reported on the prevalence of personality disorders among 644 
adult residents of two upstate New York counties who were screened as part of the longitudinal 
Children in the Community Study. Screening instruments were the Children in the Community-
Self Report scales (CIC-SR) and the screener accompanying the Structured Clinical Interview for 
DSM-IV Axis II (SCID-II), the SCID-II-PQ. The SCID-II was then administered in an 
abbreviated fashion, omitting follow-up questions for those respondents who did not endorse 
enough screening questions to warrant further inquiry. The stability of BPD in the study cohort, 
as well as the cumulative prevalence for BPD from age 14 to age 33, are also available in 
separate reports.16-18 
The National Comorbidity Survey Replication (NCS-R)19 aimed to update the state of 
knowledge about the epidemiology of mental disorders in the United States, using DSM-IV 
criteria and an expanded list of assessed diagnoses. Importantly for BPD, the NCS-R assessed 
personality disorders with the IPDE Screening Questionnaire and the IPDE itself for individuals 
screening positive. 9282 adults received face-to-face interviews between 2001 and 2003.  
Lenzenweger and colleagues20 reported on 12-month BPD prevalence in a probability subsample 
of 214 respondents who received a “clinical reappraisal” interview. This subsample over-
sampled those who screened positive for one of the “core” clinical disorders but also included 
some individuals who did not screen positive. 
The National Epidemiological Survey on Alcohol and Related Conditions (NESARC) is 
a community-based survey of adults from all 50 U.S. states and the District of Columbia. Face-
to-face interviews were conducted with over forty thousand respondents by census workers with 
minimal experience, who used an unvalidated Axis II diagnostic instrument, the Alcohol Use 
Disorder and Associated Disabilities Interview Schedule-DSM-IV (AUDADIS-IV). Lifetime 
BPD was assessed at Wave 2 of the study,21 which involved re-interviews of Wave 1 respondents 
(34,653 of 43,093 Wave 1 respondents gave re-interviews, or 86.7%). Importantly, Grant and 
colleagues gave a lifetime BPD diagnosis if sufficient BPD symptoms were present and at least 
one symptom was associated with significant distress, impairment or dysfunction. This method 
resulted in a lifetime prevalence estimate of 5.9%. However, some authors criticized this report 
as being overly inclusive, and resulting in exaggerated PD prevalence estimates. Trull, Jahng, 
Tomko, Wood and Sher22 revised the original NESARC scoring to require significant distress or 
impairment be present to count each PD criterion individually, rather than cumulatively. The 
authors then applied this revision to original NESARC algorithms, reporting a revised prevalence 
rate of 2.7%.  
Major Epidemiological Studies of BPD in non-US Communities 
 Several studies of BPD prevalence in communities outside the United States have also 
been conducted. For example, Torgersen, Kringlen, and Cramer23 sampled individuals from the 
National Register of Oslo, Norway. Personality disorders were assessed with the SIDP-R, which 
was administered by nurses, medical students, and lay interviewers. Of the 3590 individuals 
selected for inclusion, 2053 (57%) were interviewed. 
 Coid and colleagues24 reported results of a national survey of adult community members 
in England, Wales, and Scotland. Initial screening for personality disorders was conducted under 
the British National Survey of Psychiatric Morbidity, which used computer-assisted interviews. 
Subsamples of the individuals screening positive in stage 1 for psychosis or a personality 
disorder, as well as a subsample screening negative for all disorders, were offered follow-up 
interviews. The stage 1 screening sample consisted of 8886 adults, of whom 628 individuals 
completed a follow-up interview with the SCID-II. 
 Zanarini and colleagues25 reported on a survey of a cohort of 11-year-old community 
participants in Bristol, England, who were part of the Avon Longitudinal Study of Parents and 
Children (ALSPAC). These children were interviewed with the UK Childhood Interview for 
DSM-IV Borderline Personality Disorder (UK-CI-BPD), which was based on the Diagnostic 
Interview for DSM-IV Personality Disorders (DIPD-IV) but has modified language, content, and 
structure to accommodate juvenile respondents. 6,330 children gave complete interviews. 
 Finally, ten Have and colleagues26 reported on BPD prevalence among adults in the 
Netherlands, using a sample from the Netherlands Mental Health Survey and Incidence Study-2 
(NEMESIS-2). Like the British National Survey of Psychiatric Morbidity,24 an initial stage of 
computer-assisted interviews was conducted on a probability sample of individuals (n = 6646). 
However, unlike that study, all respondents from this initial wave were approached for a follow-
up interview including the eight BPD items from the IPDE, which were incorporated into the 
CIDI. 5,303 individuals were included in the second-wave sample. 
Community Subpopulations: BPD Prevalence in Adolescents and Older Adults 
Despite evidence that BPD emerges in adolescence, it has typically been thought of as an 
adult disorder. There has been resistance to diagnose it before the age of 18 on the basis that 
personality has yet to solidify and that instability in identity and relationships is part of 
normative development. However, due to the seriousness of the disorder and marked burden on 
not only the individual but on the health care system, research efforts have shifted to focus on 
early detection and prevention.27-28 These efforts parallel several recent findings that the BPD 
diagnosis can indeed be made in adolescents with adequate reliability, stability, and validity.29-30 
 A systematic review31 found that rates of BPD in adolescent samples varied substantially 
depending on study design and sample characteristics but overall tended to be higher than adult 
samples. For example, Levy and colleagues32 found rates of BPD to be 43% in an adolescent 
inpatient unit (mean age 15.5). Similar results were found by Grilo and colleagues,33 with BPD 
prevalence rates of 49% in adolescent inpatients. Outside of inpatient settings, community and 
clinical prevalence rates of BPD in adolescents tend to look similar to adult cohorts,20 with 
estimates ranging from 0.9%34 to 3%16 in community samples and 11% in outpatients.35 Of note, 
while BPD tends to be more prevalent in adult women than adult men, this gender split is not 
apparent among adolescents.31  
While research shows that some personality pathology is exacerbated across the lifespan, 
BPD has been found to decrease and even remit as individuals age.36-37 A review of personality 
disorder prevalence in younger and older age groups found rates of BPD to be significantly 
lower in older adults as compared to younger adults.38 For example, one study found a 
prevalence rate of 22% in a sample of young adults and a rate of 7% in an elderly sample.39 
Another study found a BPD prevalence rate of 1% in a community sample of 200 adults over the 
age of 60.40 Finally, a recent report of personality disorders in a community sample of 
individuals aged 55 to 64 found a BPD prevalence rate of 0.4%.41 It has been hypothesized that 
this decrease in prevalence is secondary to “burnout” in symptoms such as impulsivity or lost 
social connections and therefore less interpersonal instability.36 A majority of the research on 
prevalence rates is cross-sectional in design and more longitudinal studies extending into later 
life are needed with regards to aging and prevalence of BPD.   
Community Settings: University 
 An important community setting to consider when looking at diagnostic prevalence of 
any psychiatric disorder is universities. Given the high risk for suicide and comorbid disorders 
such as substance abuse, gaining estimates of BPD among university students is warranted. An 
early estimate of BPD prevalence among college students comes from Lenzenweger and 
colleagues,42 who applied a two-stage diagnostic procedure to a large sample of college students 
in Ithaca, New York involving the IPDE-SQ and the IPDE. This study uncovered a point 
prevalence of 1.3%, although follow-up studies highlighted striking differences in the trajectories 
of PD symptoms in this cohort over a four-year period.43 This suggests that a BPD diagnosis may 
not be stable among undergraduates, perhaps due to their relative youth or the fact that they are 
generally high-functioning compared to other community populations. A recent meta-analysis 
found that reported rates of BPD among college samples ranged from as low as 0.5% to as high 
as 32.1%, likely reflecting the varying methodology among primary studies. Moreover, there was 
an average lifetime prevalence rate of 9.7% in this population, and BPD prevalence was 
significantly lower in Asian American college students than in other racial or ethnic groups. 44 
Community Settings: Forensic  
 Highly prevalent in community and clinical populations, research indicates that rates of 
BPD are higher still in forensic settings.45-48 Black and colleagues45 found a prevalence rate of 
29.5% among a randomly selected sample of 220 individuals recently committed to prison. 
Within this sample, the prevalence of BPD in female offenders was more than twice the 
prevalence seen in male offenders (54.5% and 26.8% respectively). In a female inmate sample, 
Jordan and colleagues47 found a similar overall BPD prevalence rate of 28%.  In a small male 
prison sample, Davison, Leese, and Taylor49 found a 45% rate of BPD using the SCID-II. 
Overall, research suggests that prevalence of BPD in a forensic setting falls between about 25% 
and 55%. Additional research is needed as to comorbidities and outcomes for individuals with 
BPD in prison settings.         
Clinical Epidemiology of BPD: Psychiatric Care Settings 
 In comparison to the general community population, BPD is highly prevalent in various 
types of psychiatric settings.50 Table 2 summarizes prevalence estimates of BPD in studies of 
psychiatric populations, focusing on samples that consist of consecutively admitted patients or 
other naturalistic groups. The mean prevalence rate of BPD among inpatient samples across 
these studies, weighted by sample size, is 22.4%, whereas the comparable mean for outpatient 
samples is 11.8%. As above, we wish to highlight the discrepancy in prevalence estimates 
derived from diagnostic practice “as usual” from those estimates derived through either a well-
validated interview or a diagnostic process with deliberate attention to personality pathology. For 
example, Kantojärvi and colleagues’ inpatient prevalence estimate of 5.6%, derived through 
review of hospital records,51 is markedly lower than the inpatient average.  
 We also wish to highlight the Rhode Island Methods to Improve Diagnostic Assessment 
and Services (MIDAS) project, an ongoing study of diagnostic methods that has amassed a 
sample size of 3800 treatment-seeking outpatients.52 To date, this is by far the largest outpatient 
sample to be diagnosed with semi-structured diagnostic interviews, and as such, it provides 
perhaps the best single estimate of the outpatient prevalence of BPD. The most up-to-date 
estimate of BPD prevalence from the MIDAS project found 390 individuals with BPD among 
3674 individuals completing the SIDP-IV (10.6%).53 
Clinical Settings: Primary Care 
Whether an individual seeks consultation explicitly for their psychiatric symptoms or 
whether screened for psychopathology by their physician during routine medical practice, the 
gateway to psychiatric care for many individuals is through primary care providers. While there 
is substantial information on the epidemiology of depression and anxiety in primary care 
settings, little is known about the prevalence of BPD in such facilities. One problem is that 
screening and assessment for BPD in primary care is lacking. For example, an examination of 
computerized databases of primary care records in the Catalan Health Institute in Spain54 found a 
prevalence of recorded BPD of only 0.017%, much lower than the prevalence in the general 
population. This large discrepancy raises issues around screening for psychiatric disorders, 
particularly BPD in primary care samples given the high rates of medical comorbidities in this 
population. Likewise, a study in an urban primary care practice found that 42.9% of cases later 
identified to have BPD had not been recognized as having psychiatric difficulties of any kind by 
their primary care physicians.55 Given the increased risk of suicide and impaired psychosocial 
functioning, the authors of this study argued that properly assessing BPD is vital to better 
predicting and preventing potential ruptures in treatment and foreseeing issues in the patient-
physician relationship. Further epidemiological studies are needed with regards to BPD in 
primary care settings and behavioral medicine, with the ultimate goal of improving screening 
practices to help triage patients to appropriate treatment. 
Clinical Settings: Non-Psychiatric Specialty Care 
Reviews of the prevalence of BPD in medical settings suggest that individuals with BPD 
have been shown to be especially common among those presenting in medical settings with 
alcohol and substance use disorders, multiple somatic complains, chronic pain, obesity, sexual 
dysfunction (including sexual dissatisfaction and promiscuity), and trichotillomania.56-57 This 
finding is essentially consistent with recent reviews documenting high levels of physical health 
problems among individuals with BPD.58-59 It should be noted that the research basis for the 
connections between BPD and these physical complaints varies considerably in both quantity 
and quality; many primary studies used convenience samples rather than probability samples, 
self-report measures or chart review rather than well-validated diagnostic interviews, or had 
excessively small sample sizes. 
Further reviews and primary studies have identified other specialty medical settings 
where individuals with BPD can be found in large numbers, such as aesthetic plastic surgery 
(especially to repair scars from deliberate self-injury)60 and bariatric surgery.61 Many of the 
large-scale epidemiological studies reviewed above have also provided their own evidence that 
Borderline Personality Disorder is associated with a wide array of physical health conditions.62-65 
In short, there is suggestive to strong evidence to indicate that BPD is prevalent among 
individuals seeking care for a wide variety of physical health complaints. 
Given that personality pathology frequently co-occurs with alcohol and drug addiction, 
high rates of BPD are seen in substance abuse clinics and programs. One study66 surveyed 320 
patients enrolled in an outpatient addictions service targeting alcohol and opiate dependence and 
found the prevalence rate of personality disorders to be 62.2%. While 0% of the sample met 
criteria for schizotypal personality disorder and 13.8% qualified for an antisocial personality 
disorder diagnosis, BPD had the highest prevalence of any specific personality disorder at 15%. 
The authors also reviewed principal studies in the literature regarding the prevalence of 
personality pathology in substance abusing samples and found that the rates of BPD varied 
substantially between 3.2%67 and 65.1%.68   
Summary and Areas in Need of Research 
In sum, BPD is relatively common in the general population, with a point prevalence 
around 1%. There are also subpopulations in which the prevalence is higher (e.g., incarcerated 
individuals) or lower (e.g., elderly individuals) than this. The prevalence of BPD is substantially 
higher in clinical settings, around 12% in the outpatient psychiatric population and 22% among 
inpatients. Although there are no well-established prevalence rates in primary care, there is 
reason to believe that BPD is quite common among individuals seeking medical care for a 
variety of physical conditions.  
There are some areas in which the epidemiology of BPD would particularly benefit from 
additional research. For example, although extant studies of racial and ethnic differences in the 
community prevalence of BPD do not show systematic differences,21,69 a recent review identified 
racial differences in BPD prevalence in more specific settings.70 Research also suggests that 
there may be differences among ethnic groups in the prevalence and extent of many indicators of 
BPD, such as suicidality71-72 and deliberate self-harm.73 In addition, the association between 
deliberate self-harm and borderline personality features differs among ethnic groups,74 and 
African-American individuals with BPD have been shown to report more affective instability 
and emotion dysregulation, but less suicidal behavior and deliberate self-harm, than White 
American individuals with the disorder.75-76 Systematic studies of this topic are few, as are 
studies of the impact of other demographic variables (e.g. socioeconomic status) on BPD 
presentation and prevalence. Our knowledge of BPD’s epidemiology would be strengthened with 
greater attention to these important issues.  
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 Table 1.—Epidemiological Studies of BPD Prevalence in Community Samples 
Study N Location 
Criterion 
Set Used BPD Measure 
Prevalence 
(%) 
Reich et al.77 (1989) 401 Iowa, USA DSM-III PDQ 1.3 
Swartz et al.10 (1990) 1541 North 
Carolina, 
USA 
DSM-III DIS 1.8 
Torgersen et al.23 
(2001) 
2053 Oslo, 
Norway 
DSM-III-R SIDP 0.7 
Samuels et al.12 (2002) 742 Maryland, 
USA 
DSM-IV IPDE 0.5 
Crawford et al.15 
(2005) 
716 New York, 
USA 
DSM-IV CIC-SR 2.2 
Coid et al.24 (2006) 626 Great Britain DSM-IV SCID-II 0.7 
Lenzenweger et al.20 
(2007) 
5692 continental 
USA 
DSM-IV IPDE 1.4 
Trull et al.22 (2010) 34653 USA DSM-IV AUDADIS-IV 2.7 
Zanarini et al.25 (2011) 6330 Bristol, 
England 
DSM-IV UK-CI-BPD 3.2 
ten Have et al.26 
(2016) 
5303 Netherlands DSM-IV IPDE 1.1 
PDQ = Personality Diagnostic Questionnaire; DIS = Diagnostic Interview Schedule; 
SCID-II = Structured Clinical Interview for DSM Personality Disorders; SIDP = Structured 
Interview for DSM Personality Disorders; IPDE = International Personality Disorders 
Examination; CIC-SR = Children in the Community Self Report Scales; UK-CI-BPD = UK 
Childhood Interview for DSM-IV Personality Disorder; AUDADIS-IV = Alcohol Use Disorder 
and Associated Disabilities Interview Schedule for DSM-IV 
 
 
  
Table 2.—Epidemiological Studies of BPD Prevalence in Psychiatric Samples 
Study N Setting 
Criterion 
Set Used BPD Measure 
Prevalence 
(%) 
Stangl et al.78 (1985) 131 Inpatient 
and 
outpatient 
DSM-III SIDP 22.1 
Kass et al.79 (1985) 609 Outpatient DSM-III clinical 11.0 
Koenigsberg et al.80 (1985) 2462 Mixed DSM-III clinical 12.3 
Dahl81 (1986) 231 Inpatient DSM-III SIB 20.3 
Fabrega et al.82 (1993) 18179 Evaluation DSM-III clinical 2.1 
Herpertz, Steinmeyer, & 
Saß83 (1994) 
231 Inpatient DSM-III-R AMPS 13.6 
Molinari et al.39 (1994) 200 Inpatient DSM-III-R SIDP-R 6.5 
Oldham et al.84 (1995) 100 Outpatient 
evaluation 
DSM-III-R PDE 18.0 
Oldham et al.84 (1995) 100 Inpatient 
evaluation 
DSM-III-R PDE 64.0 
Grilo et al.33 (1998) 138 Inpatient DSM-III-R PDE 49.3 
Grilo et al.33 (1998) 117 Inpatient DSM-III-R PDE 42.7 
Ottosson et al.85 (1998) 138 Mixed DSM-IV DIP-I 33.3 
Marinangeli et al.86 (2000) 156 Inpatient DSM-III-R SCID-II 40.4 
Fossati et al.87 (2000) 431 Inpatient 
and 
outpatient 
DSM-IV SCID-II 22.5 
Chanen et al.35 (2004) 101 Outpatient DSM-IV SCID-II 10.9 
Kantojärvi et al.51 (2004) 444 Inpatient DSM-III-R clinical 5.6 
Korzekwa et al.88 (2008) 360 Outpatient DSM-IV DIB-R 22.6 
Kaess et al.89 (2013) 87 Inpatient 
and 
outpatient 
DSM-IV SCID-II 35.6 
Ha et al.90 (2014) 418 Inpatient DSM-IV CI-BPD 32.8 
Comtois & Carmel7 (2016) 159 Outpatient DSM-IV PDE 15.1 
Zimmerman et al.53 (2017) 3674 Outpatient DSM-IV SIDP 10.6 
SCID-II = Structured Clinical Interview for DSM Personality Disorders; SIDP = 
Structured Interview for DSM Personality Disorders; PDE = Personality Disorders Examination; 
SIB = Schedule for Interviewing Borderlines; AMPS = Aachen List of Items for the Registration 
of Personality Disorders; DIP-I = DSM-IV and ICD-10 Personality Interview; DIB-R = Revised 
Diagnostic Interview for Borderlines; CI-BPD = Childhood Interview for DSM-IV Borderline 
Personality Disorder. 
